As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...

(HealthDay News) — Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in a news ...

Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...

As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...

The Health and Human Services Department won’t issue health advisories, reports or other materials until further notice, with ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

And remember, Medicare provides access to about 8,000 drugs ... but what I will tell you is there is a core of personnel at HHS, regardless of administration, that has done dramatically important ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...

The exact scope and duration is clear, and one question is what will happen to release of CDC data that employers and insurers use in pricing.

Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...